DCI biostatistician and professor Susan Halabi, PhD, received, from the University of Alabama, an award for Outstanding Achievement by a Woman in Statistical Sciences.
Various genetic alterations in circulating tumor cells were associated with clinical outcomes and resistance to hormone therapy in patients with mCRPC.
Susan Halabi, PhD, is co-leading a project to create a large international registry of data from prostate cancer patients treated with various PARP inhibitors.
Here are some of the DCI physicians, physician-scientists, researchers & nurses whose work has recently been featured by the media, academic trade publications & journals.
Duke Cancer Institute will present more than 100 abstracts across multiple cancer types during the ASCO20 Virtual Scientific Program of the 2020 ASCO Annual Meeting.
Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.
Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.
Black men are underrepresented in clinical trials for prostate cancer, despite an almost two-fold greater incidence and mortality of disease in black versus white populations.
When taking into account certain variables that affect survival, whites fare worseContrary to current perceptions, certain African-American men with a...
A Conversation with Mike Krzyzewski: Duke men’s basketball head coach (St. Helena Star/Napa Valley Register)
Features Mike Krzyzewski on anti-cancer ...
Susan Halabi, PhD, professor of Biostatistics and Bioinformatics, was named in June a Fellow of the American Statistical Association (ASA), the nation...
Patients with lymph-only metastasis have the longest overall survival, while those with liver involvement fare worst. Lung and bone metastasis fall in...